Top Gainers for 1-21-20: $GNPX $NVAX $VIVE

$GNPX - Genprex Receives U.S. FDA Fast Track Designation for Gene Therapy that Targets Lung Cancer: https://finance.yahoo.com/news/genprex-receives-u-fda-fast-130000971.html

$NVAX - Novavax shares jump 60% in premarket trading (Heavy Volume): https://finance.yahoo.com/m/70a70a59-6e88-3875-8fae-c3f6c7aecfd6/novavax-shares-jump-60%25-in.html

$VIVE - Viveve Initiates Enrollment of its Short-Term Feasibility Study in Stress Urinary Incontinence: https://finance.yahoo.com/news/viveve-initiates-enrollment-short-term-132800890.html